Similar companies
Related EMIS Industry Reports
The company is a listed company whose operation is across chemical and pharmaceutical industries. The company business has four large sections: new energy, synthetic resins, bulk drugs, intermediates and pharmaceutical preparations with more than 100 kinds of products. Company is mainly engaged in pharmaceutical intermediates, bulk drugs and pharmaceutical preparations and other products, R&D and manufacturing as well as dimethyl ether and other new energy manufacturing. In the field of raw material production for anti-inflammatory drugs, the company owns ibuprofen manufacturing equipment with annual output of 3800 tons, which rank third in the world, the first in China. Many of its bulk drugs have passed FDA site inspection and COS certification. The company is one of high-tech enterprises of Hubei province.
Headquarters
132 Yangwan Rd. Jingmen Hubei
Jingmen; Hubei;
Postal Code: 448000
Contact Details: Purchase the Hubei Biocause Pharmaceutical Co.,Ltd. report to view the information.
Website: http://www.tianmaogroup.net
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service